Suchergebnisse - "Martin, Thomas C. S."

PubPharm (36)

1

Relative Cost and Infectious Days Averted Associated With Rapid Gonorrhea and Chlamydia Testing Among Men Who Have Sex With Men

enthalten in: Sexually transmitted diseases | 2024

von Welford, E. | Martin, T. | Martin, N. | +2

2

Effects of a hospital discharge clinic among people with HIV : Lack of early follow-up is associated with 30-day hospital readmission and decreased retention in care

enthalten in: HIV medicine | 2024

von Hill, L. | Thompson, C. | Balcombe, S. | +7

3

Annual N95 respirator fit-testing : an unnecessary burden on healthcare

enthalten in: Infection control and hospital epidemiology | 2024

von Martin, T. | Curtin, G. | Martin, N. | +1

4

Effects of a hospital discharge clinic among people with HIV : Lack of early follow‐up is associated with 30‐day hospital readmission and decreased retention in care

enthalten in: HIV Medicine | 2024

von Hill, L. | Thompson, C. | Balcombe, S. | +7

5

Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial

enthalten in: The Journal of infectious diseases | 2023

von Rouphael, N. | Branche, A. | Diemert, D. | +135

UpdateOf: medRxiv. 2023 Jun 10;:. - PMID 37333252

6

Risk of COVID-19 after natural infection or vaccination

enthalten in: EBioMedicine | 2023

von Rick, A. | Laurens, M. | Huang, Y. | +125

7

Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines : the phase 2 randomized open-label COVAIL trial

enthalten in: Nature medicine | 2023

von Branche, A. | Rouphael, N. | Diemert, D. | +141

UpdateOf: Res Sq. 2023 May 05;:. - PMID 37205592

8

Reply to Montastruc et al

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Birabaharan, M. | Martin, T. | Mehta, S.

9

4th Generation HIV screening in the emergency department : net profit or loss for hospitals?

enthalten in: AIDS care | 2023

von Hoenigl, M. | Lo, M. | Coyne, C. | +7

10

Cardiovascular Outcomes After Tixagevimab and Cilgavimab use for Pre-Exposure Prophylaxis Against Coronavirus Disease 2019 : A Population-Based Propensity-matched Cohort Study

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Birabaharan, M. | Hill, E. | Begur, M. | +3

CommentIn: Clin Infect Dis. 2023 Jun 8;76(11):2044-2045. - PMID 36799347